Patents by Inventor RICHARD D. WOESSNER

RICHARD D. WOESSNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT USING INHIBITORS OF MITOSIS
    Publication number: 20180338958
    Abstract: Methods of treating diseases caused by cell division or that are treated by inhibiting mitosis by administering two doses of an inhibitor of mitosis between the biologically effective dose and the maximum tolerated dose in a dosing cycle that allows for the recovery or subsiding of side effects, wherein the second dose is administered 24 to 48 hours after the first dose.
    Type: Application
    Filed: June 5, 2018
    Publication date: November 29, 2018
    Applicant: Array BioPharma Inc.
    Inventors: Brian J. Tunquist, Duncan HL. Walker, Richard D. Woessner
  • METHOD OF TREATMENT USING INHIBITORS OF MITOSIS
    Publication number: 20170172988
    Abstract: Methods of treating diseases caused by cell division or that are treated by inhibiting mitosis by administering two doses of an inhibitor of mitosis between the biologically effective dose and the maximum tolerated dose in a dosing cycle that allows for the recovery or subsiding of side effects, wherein the second dose is administered 24 to 48 hours after the first dose.
    Type: Application
    Filed: December 28, 2016
    Publication date: June 22, 2017
    Applicant: Array BioPharma Inc.
    Inventors: Brian J. Tunquist, Duncan H. Walker, Richard D. Woessner
  • Method of treatment using inhibitors of mitosis
    Patent number: 9561214
    Abstract: Methods of treating diseases caused by cell division or that are treated by inhibiting mitosis by administering two doses of an inhibitor of mitosis between the biologically effective dose and the maximum tolerated dose in a dosing cycle that allows for the recovery or subsiding of side effects, wherein the second dose is administered 24 to 48 hours after the first dose.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: February 7, 2017
    Assignee: Array BioPharma Inc.
    Inventors: Brian J. Tunquist, Duncan H. Walker, Richard D. Woessner
  • Method of Treatment Using Inhibitors of Mitosis
    Publication number: 20100099697
    Abstract: Methods of treating diseases caused by cell division or that are treated by inhibiting mitosis by administering two doses of an inhibitor of mitosis between the biologically effective dose and the maximum tolerated dose in a dosing cycle that allows for the recovery or subsiding of side effects, wherein the second dose is administered 24 to 48 hours after the first dose.
    Type: Application
    Filed: October 16, 2009
    Publication date: April 22, 2010
    Applicant: ARRAY BIOPHARMA INC.
    Inventors: Brian J. Tunquist, Duncan H. Walker, Richard D. Woessner
  • SHORT OLIGONUCLEOTIDES FOR THE INHIBITION OF VEGF EXPRESSION
    Publication number: 20010021772
    Abstract: VEGF (vascular endothelial growth factor) is a key regulator of angiogenesis, and agents that selectively decrease the VEGF levels may be used to treat malignancies and other angiogenic diseases characterized by high degree of vascularization or vascular permeability. A short oligonucleotide, or a derivative thereof, which has a sequence that corresponds to a particular part of a nucleic acid sequence which encodes VEGF, and which has a maximum length of 15 nucleotides, selectively inhibits VEGF expression. The invention further relates to a method of making the oligonucleotide and the use thereof.
    Type: Application
    Filed: August 2, 1999
    Publication date: September 13, 2001
    Inventors: EUGEN UHLMANN, ANUSCHIRWAN PEYMAN, ALAN J. BITONTI, RICHARD D. WOESSNER